Articles On Cann Group (ASX:CAN)

Title Source Codes Date
September
Health Winners: EZZ and Althea lead upbeat sector sparked by Fed rate cut

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

Stockhead CAN 3 days ago
ASX September Winners: The 50 best stocks in a strong month for markets

Renewed optimism lifted the S&P/ASX 200 by 3% in September, closing at a record 8,239.20 points S&P Dow Jones Indices said small cap companies outperformed in September, with the materials sector rebounding 13%  Mithril Silver and...

Stockhead CAN 3 days ago
Closing Bell: Sigma soars 22pc, Qantas feels heat from Qatar, and traders cash in on miners’ rally

ASX dips as miners lead selloff as Chinese markets close for holidays Sigma Healthcare soars 22pc after merger update Qantas tumbles 4pc as Qatar eyes Virgin Australia stake   The ASX dipped  from its record high as miners led the sellof...

Stockhead CAN 4 days ago
Closing Bell: Another China boost for mining stocks; Odessa soars 150pc on uranium project backing

ASX rises modestly with mining stocks leading gains Fortescue surges nearly 5pc as iron ore prices climb on fresh China stimulus Odessa soars on news of a $1,1m placement to secure exploration at its Lyndon uranium project   The ASX scal...

Stockhead CAN 5 days ago
Closing Bell: Investors rush to mining stocks after China news; while Star crashes 40pc to new low

  ASX rises modestly with mining stocks leading gains Fortescue surges nearly 5pc as iron ore prices climb Star Entertainment plunges over 40pc after trading halt lifted   The ASX rose modestly by 0.1% on Friday, buoyed by a surge in min...

Stockhead CAN 1 week ago
Closing Bell: Iron ore giants help ASX to another record; RBA rate cut far-off as job market stays tight

ASX200 hits record high driven by US Fed interest rate cut Mining stocks surge as iron ore prices rebound ALS shares drop 10pc, Monadelphous rises on new contracts   The ASX200 hit yet another record high today, boosted by the first inte...

Stockhead CAN 2 weeks ago
July Health Winners: Oncosil, Zelira lead as ASX biotechs power through another strong month

S&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expected Fed rate cuts; ResMed seen as a strong buy And ASX healthcare winners and losers in July   The S&P/ASX 200 Health Care index [XHJ]...

Stockhead CAN 2 months ago
Check Up: Europe delivers blow to Alzheimer’s research; and recent ASX health stock winners

The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month   In a major blow for...

Stockhead CAN 2 months ago
Weed Week: Getting a grip on the cannabis scene amid a pending regulatory shakeup

The cannabis industry is poised for growth, driven by evolving legalisation globally Investment opportunities therefore exist across the sector We take a look at the ASX weed stock winners over the past month    The cannabis industry is c...

Stockhead CAN 2 months ago
ASX Health June Winners: Actinogen and Optiscan led a sector in good shape

The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others    The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase...

Stockhead CAN 3 months ago
ASX June Winners: The best 50 stocks as inflation spikes

S&P/ASX 200 rose 1% in June with large caps leading gains with mid, small and emerging companies lagging S&P/ASX 200 financials and consumer staples were the top performers in June with materials the biggest laggard Urea fertiliser...

Stockhead CAN 3 months ago
Weed Week: MDMA for PTSD hits roadblock with FDA; and recent ASX cannabis stock winners

FDA panel rejects MDMA for PTSD treatment, citing safety and data concerns Advocates argue MDMA’s benefits outweigh risks, call for further research. South Africa legalises personal cannabis use, setting precedent for African nations    G...

Stockhead CAN 3 months ago
Closing Bell: Aussie shares slip on commodities dip; but Goldies soar on rates hopes

Aussie shares down on weaker commodities Iron ore and energy stocks slip, while goldies gain Intel CEO Pat Gelsingers takes swipe at Nvidia’s CEO Jensen Huang   Aussie shares dropped slightly on Tuesday, closing -0.2% lower as the impact...

Stockhead CAN 4 months ago
Top 10 at 10: Discoveries and a $200m rare earths, mineral sands payday

Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead CAN 4 months ago
ASX Health Winners in May: LTR Pharma leads, and why hopes are high for biotech stocks this year

 S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month   The  S&P/ASX 200 Health Care [XHJ] closed flattish for the month o...

Stockhead CAN 4 months ago
Cann Group secures funding for next 12 months with $5m lifeline

As Cann Group (ASX: CAN) looks to finally reap the fruits of its capital-intensive $115 million Mildura production and manufacturing facility, the fast-growing medicinal cannabis company has been pulling out all stops to shore up finances a...

businessnewsaustralia.com CAN 4 months ago
ASX Health Winners April: Mesoblast leads; and why the Health sector is just built different

ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month   The S&P/ASX 200 Health Care [XHJ] had a soft month in April...

Stockhead CAN 5 months ago
Could ASX cannabis shares be set for a smoking hot rebound?

With a few notable exceptions, ASX cannabis shares widely underperformed again over the last year. That's a far cry from the heady days of 2019 and 2020 when ASX cannabis shares joined their American-listed peers in setting investors' portf...

Motley Fool CAN 5 months ago
Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners

There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month   Scientists have made a significant b...

Stockhead CAN 5 months ago
Things you may not know about Made in Australia, and ASX stocks that manufacture right here

Albanese govt announces the Future Made in Australia Act Why supporting Australian Made is a win-win game Stockhead reached out to Australian Made CEO, Ben Lazzaro   The ambitiously named Future Made in Australia Act was launched a couple...

Stockhead CAN 5 months ago
Weed Week: A VAST majority of Americans now want marijuana to be legal

Where are we in terms of US legalisation of cannabis? What about the current legal landscape for cannabis in Australia? We look at the best performing ASX weed stocks this past month   Global weed stocks have been on bumpy ride over the p...

Stockhead CAN 5 months ago
Cann Group CEO resigns after just 14 months at the helm

Cann Group (ASX: CAN) CEO Peter Koetsier has tendered his resignation just 14 months after assuming leadership of the medicinal cannabis company, which is growing sales at a fast clip but remains burdened by the debts incurred as a result o...

businessnewsaustralia.com CAN 6 months ago
Playing with fire: The dangers of chasing hot trends

Content Director Patrick Poke of Betashares explores the risks associated with impulsively reacting to investment trends fuelled by media hype, and explain why prudent asset selection, diversification, and maintaining a composed approach ar...

Rask Media CAN 6 months ago
Weed Week: Cannabis can ‘kill melanoma’; and Germany legalises weed possession

Study shows cannabis can kill melanoma cells Germany has voted to legalise cannabis possession The best performing ASX weed stocks over the past month   It hasn’t been a stellar month for global cannabis stocks, with the index falling by...

Stockhead CAN 6 months ago
ASX Health Winners February: Law of attrition applies but biotech is a long term game; Nyrada up 5x last month

ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors   The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr...

Stockhead CAN 6 months ago
Going concerns notices raised for ASX cannabis players Cann Group and Althea

Material uncertainties have been raised about two of the largest medicinal cannabis companies listed on the ASX to continue as going concerns, after Cann Group (ASX: CAN) and Althea Group (ASX: AGH) incurred December half losses of $14.3 mi...

businessnewsaustralia.com CAN 7 months ago
Check Up: Big week in world of biotech after these 2 Nasdaq stocks announce breakthroughs

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

Stockhead CAN 7 months ago
Weed Week: Iron Mike throws down challenge to Biden, and recent ASX pot winners

Mike Tyson has spoken out against the jailing of cannabis users Iron Mike owns his own cannabis brand called TYSON 2.0 We take a look at the best performing ASX weed stocks over the past month    There are currently at least 3,000 individ...

Stockhead CAN 7 months ago
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...

Stockhead CAN 10 months ago
Weed Week: Jamaican nettletree could be a new, cheaper option to source CBD, says scientists

Jamaican nettletree is said to contain traces of cannabidiol (CBD) Victoria set to launch a medical cannabis driving trial for patients  How ASX weed stocks have performed over the past week and month   Scientists in Brazil said they’ve d...

Stockhead CAN 10 months ago
Weed Week: US House Speaker ousting could boost weed stocks; TGA urged to allow the term ‘medicinal cannabis’

Cannabis stocks could rise after the removal of US House Speaker Montu says TGA has to allow the term ‘medicinal cannabis’ to be used We look at the best performing ASX weed stocks over the past month   Some experts believe cannabis stock...

Stockhead CAN 11 months ago
Weed Week: Big win for cannabis as SAFER Banking Act approved; market remains robust in Australia

Big win for cannabis as SAFER Banking Act set to be passed in the US Australia’s cannabis industry remains robust this year, says TGA We look at how ASX weed stocks have performed over the past weeks   A huge win for cannabis as US SAFER...

Stockhead CAN 11 months ago
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it

L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks   Be...

Stockhead CAN 1 year ago
Weed Week: Short sellers burned as cannabis stocks stage a rebound. Where to next?

Cannabis stocks are rebounding, catching short sellers off guard Next signpost for weed investors is the Section 280E of the US IRS tax code We take a look at the best performing weed stocks in last couple of weeks   Having been mauled fo...

Stockhead CAN 1 year ago
Check Up: What is the FDA emergency use authorisation, and which ASX stocks were given approval?

The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks   On...

Stockhead CAN 1 year ago
Weed Week: Growing excitement for cannabis stocks after marijuana rescheduling hopes in the US

Cannabis stocks jumped after marijuana rescheduling recommendation in the US Study in Australia shows cannabis is effective on a range of conditions We take a look at the best performing ASX stocks over the past week   Cannabis stocks ope...

Stockhead CAN 1 year ago
ASX Biotech August Winners: Sector down despite CSL and Cochlear’s strong results, but don’t panic…

Earnings reports dominated headlines in August Despite solid results from ASX healthcare giants, the sector finished lower We take a look at which ASX healthcare stocks performed the best in August   August was all about earnings, and des...

Stockhead CAN 1 year ago
Check Up: Australian biotech sector continues to be a magnet for US investors

Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the  best and worst performing ASX biotechs over the past month   The Australian biotech sector co...

Stockhead CAN 1 year ago
Weed Week: ‘Welcome to the psychedelic 2020s!’ as market holds breath on key US approval

The US is about to follow Australia’s footsteps and approve psychedelics The FDA is currently awaiting a pivotal survey conducted by MAPS And here’s how the ASX weed stocks have performed over the past week   In July of this year, Austral...

Stockhead CAN 1 year ago
Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money will go

Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month   Steve Jobs used to say that the most...

Stockhead CAN 1 year ago
Weed Week: Mastercard says NO to cannabis transactions, as New York becomes the happening place for weed

Mastercard says no to weed transactions New York is where weed is happening Jeremy Buckingham pulls a stunt at NSW Parliament   Here’s a quick snapshot of cannabis news making headlines over the past week: Mastercard has told banks to sto...

Stockhead CAN 1 year ago
ASX Health Stocks: Medibio jumps 50pc on Phase 1 results; Cann doubles cannabis harvest

Medibio jumps after completing Phase 1 clinical trial Cann Group’s latest crop harvest is at a scale twice that of previous harvests 4DMedical wins a $1.1 million from the Fed government   Microcap Medibio (ASX:MEB) jumped 50% this mornin...

Stockhead CAN 1 year ago
Dragonfly Biosciences sprouts wings for ASX IPO

Dragonfly Biosciences Limited, a prominent UK-based producer of cannabidiol (CBD) supplements and lotions, is making strides towards its IPO on the ASX next month. Regan Saveall, the CEO of Dragonfly Biosciences, expressed enthusiasm about...

ShareCafe CAN 1 year ago
Weed Week: Social media platforms scramble to update advertising policies on cannabis products

Social media platforms are rushing to update their advertising policies on cannabis Meta was the most recent platform to do so Australia’s TGA is clamping down on CBD advertising in Australia   With regulations on cannabis use moving fast...

Stockhead CAN 1 year ago
How Bod Science pulled ahead in the race for Australia’s first over-the-counter CBD

Since TGA’s down-scheduling of CBD last year, no products have been sold in Australia But the race to market has been seemingly won by Bod Science following a ‘landmark update’ Stockhead reached out to BOD’s CEO, Jo Patterson   Amidst gro...

Stockhead CAN 1 year ago
Cann Group doubles sales as Mildura cannabis crop set to triple

Medicinal cannabis company Cann Group (ASX: CAN) will start harvesting again from its Mildura facility in mid-July, with yields set to lift substantially after a financial year when sales more than doubled to reach $13.5 million, bolstered...

businessnewsaustralia.com CAN 1 year ago
Cann Group lights up medicinal cannabis market

Cann Group (ASX:CAN), a prominent player in the Australian medicinal cannabis industry, has announced its unaudited revenue results for the fiscal year 2023, showcasing remarkable growth. The company expects unaudited operating revenue of a...

ShareCafe CAN 1 year ago
Cann Group lights up medicinal cannabis market

05 Jul 2023 - Cann Group (ASX:CAN) has announced its unaudited revenue results for the fiscal year 2023, showcasing remarkable growth.

FNN CAN 1 year ago
ASX Health Stocks: Cann’s cannabis flower sales grow 500pc; Immuron runs out of Travelan as travel rebounds

Cann Group’s FY23 sales were 2.1 times that of FY22 Immuron’s FY23 sales increased by 136% from the previous year   Cann Group doubles its sales revenue Cannabis house Cann Group (ASX:CAN) rose 8% this morning after releasing its full yea...

Stockhead CAN 1 year ago
Why ASX cannabis shares just jumped back into the spotlight

ASX cannabis shares have had a tough year. That’s despite the fact that the cannabis stocks operate in a country where medicinal marijuana is technically legal. That’s enabled them to provide valuable health services to many thousands...

Motley Fool CAN 1 year ago